Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
This study has been completed.
Study NCT00500682   Information provided by Mitsubishi Tanabe Pharma Corporation

First Received on July 11, 2007.   Last Updated on October 1, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Kidney Disease
Additional conditions recognized in this trial
Kidney Diseases
Kidney Failure, Chronic
Renal Insufficiency, Chronic
More general conditions related to this trial
Renal Insufficiency
Urologic Diseases
Interventions listed in this trial
Placebo
AST-120
Sponsors listed in this trial
Mitsubishi Tanabe Pharma Corporation
Kureha Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services